Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
10 week randomised, unblinded, controlled trial.
Centres in the US.
197 homosexual men who were 18–65 years of age (mean age 38 y, 63% white, 58% HIV-1 seropositive), had lost a close friend or partner to AIDS in the previous 6 months, rated the loss as having a substantial negative effect, and were fluent in English. Exclusion criteria included prescribed medication that affected immune function, CD4 cell counts <0.05 x 109/l (50 cells/mm3), alcohol or substance dependence, previous or current psychiatric disorder, intravenous substance use in previous 2 years, surgery in the previous 6 months, smoking history of >50 pack years, and participation in clinical antiretroviral drug trials. Follow up was 84%.
Men were allocated to a bereavement support group intervention (n=92) or standard psychosocial and medical care (n=74) for 10 weeks. The intervention consisted of 90 minute weekly sessions led by 2 cotherapists who were experienced in supportive group psychotherapy for bereavement and lethal diseases.
Main outcome measure
A composite score for grief (Texas Inventory of Grief) and distress (total mood disturbance scores on the Profile of Mood States).
Men in the bereavement support group had a greater decrease in the composite grief and distress score than men in the control group (p<0.001). This difference was seen in men who tested positive (p=0.01) and negative (p=0.009) for HIV-1 (table⇓), and it remained after adjustment for educational level, income in previous month, Hispanic ethnicity, social support availability, presence of Axis II disorder, and current alcohol use (p=0.003). The bereavement support group led to a reduction in distress scores (p<0.001). This effect was seen in men who tested positive (p=0.01) and negative (p<0.001) for HIV-1 (table⇓) and remained after adjustment for age, Hispanic ethnicity, active coping frequency, presence of minor cognitive motor disorder and of Axis II disorder, and current alcohol use. No difference between groups existed for decrease in grief scores in men who tested negative and positive for HIV-1 (table⇓).
In homosexual men who have lost a close friend or intimate partner to AIDS in the previous 6 months, a bereavement support group was effective for reducing grief and distress.
The study by Goodkin et al describes the effectiveness of a professionally led, bereavement support group in reducing grief and overall distress in bereaved, homosexual men, some of whom were HIV positive. The exclusion criteria specified in the study were restrictive. In addition, although both HIV positive and HIV negative men were included in the study, only a small proportion were HIV seropositive with advanced disease. For these 2 reasons, generalisability of the study findings to more vulnerable populations (eg, those with more severe distress or psychopathology or with full-blown AIDS) is limited.
The effectiveness of brief group therapy has been shown for depressed HIV seropositive homosexual men.1 The intervention evaluated by Goodkin et al focused on grief work, life stressors, social support, and coping style. It was provided by 2 experienced cotherapists, who were not nurses and who followed a specified protocol for each weekly session.2 Others have shown that self help support groups with a clinician in the role of facilitator, rather than therapist, are effective for a wide range of health related issues, including HIV and bereavement.3 Both approaches use groups; however, the nursing role may be more consistent with that of a facilitator rather than a therapist. If nurses are interested in implementing the therapist role described in this study, they should be experienced in supportive group therapy for bereavement and carefully trained and monitored using the specified protocol.
Source of funding: National Institute of Mental Health.
For correspondence: Dr K Goodkin, Department of Psychiatry and Behavioral Sciences (M836), University of Miami School of Medicine, 1400 NW 10th Avenue, Room 803-A, Miami, FL 33136, USA. Fax +1 305 243 4062.